215 related articles for article (PubMed ID: 22945917)
1. Activity of carbapenems with ME1071 (disodium 2,3-diethylmaleate) against Enterobacteriaceae and Acinetobacter spp. with carbapenemases, including NDM enzymes.
Livermore DM; Mushtaq S; Morinaka A; Ida T; Maebashi K; Hope R
J Antimicrob Chemother; 2013 Jan; 68(1):153-8. PubMed ID: 22945917
[TBL] [Abstract][Full Text] [Related]
2. Sulfamoyl Heteroarylcarboxylic Acids as Promising Metallo-β-Lactamase Inhibitors for Controlling Bacterial Carbapenem Resistance.
Wachino JI; Jin W; Kimura K; Kurosaki H; Sato A; Arakawa Y
mBio; 2020 Mar; 11(2):. PubMed ID: 32184250
[TBL] [Abstract][Full Text] [Related]
3. In vitro potentiation of carbapenems with ME1071, a novel metallo-beta-lactamase inhibitor, against metallo-beta-lactamase- producing Pseudomonas aeruginosa clinical isolates.
Ishii Y; Eto M; Mano Y; Tateda K; Yamaguchi K
Antimicrob Agents Chemother; 2010 Sep; 54(9):3625-9. PubMed ID: 20606062
[TBL] [Abstract][Full Text] [Related]
4. Activity of BAL30072 alone or combined with β-lactamase inhibitors or with meropenem against carbapenem-resistant Enterobacteriaceae and non-fermenters.
Mushtaq S; Woodford N; Hope R; Adkin R; Livermore DM
J Antimicrob Chemother; 2013 Jul; 68(7):1601-8. PubMed ID: 23449829
[TBL] [Abstract][Full Text] [Related]
5. WCK 4234, a novel diazabicyclooctane potentiating carbapenems against Enterobacteriaceae, Pseudomonas and Acinetobacter with class A, C and D β-lactamases.
Mushtaq S; Vickers A; Woodford N; Livermore DM
J Antimicrob Chemother; 2017 Jun; 72(6):1688-1695. PubMed ID: 28333319
[TBL] [Abstract][Full Text] [Related]
6. Activity of biapenem (RPX2003) combined with the boronate β-lactamase inhibitor RPX7009 against carbapenem-resistant Enterobacteriaceae.
Livermore DM; Mushtaq S
J Antimicrob Chemother; 2013 Aug; 68(8):1825-31. PubMed ID: 23580564
[TBL] [Abstract][Full Text] [Related]
7. New Delhi Metallo-beta lactamase (NDM-1) in Enterobacteriaceae: treatment options with carbapenems compromised.
Deshpande P; Rodrigues C; Shetty A; Kapadia F; Hedge A; Soman R
J Assoc Physicians India; 2010 Mar; 58():147-9. PubMed ID: 20848811
[TBL] [Abstract][Full Text] [Related]
8. Comparative activities of doripenem versus isolates, mutants, and transconjugants of Enterobacteriaceae and Acinetobacter spp. with characterized beta-lactamases.
Mushtaq S; Ge Y; Livermore DM
Antimicrob Agents Chemother; 2004 Apr; 48(4):1313-9. PubMed ID: 15047535
[TBL] [Abstract][Full Text] [Related]
9. In vivo efficacy of biapenem with ME1071, a novel metallo-β-lactamase (MBL) inhibitor, in a murine model mimicking ventilator-associated pneumonia caused by MBL-producing Pseudomonas aeruginosa.
Yamada K; Yanagihara K; Kaku N; Harada Y; Migiyama Y; Nagaoka K; Morinaga Y; Nakamura S; Imamura Y; Miyazaki T; Izumikawa K; Kakeya H; Hasegawa H; Yasuoka A; Kohno S
Int J Antimicrob Agents; 2013 Sep; 42(3):238-43. PubMed ID: 23891525
[TBL] [Abstract][Full Text] [Related]
10. Combined use of the modified Hodge test and carbapenemase inhibition test for detection of carbapenemase-producing Enterobacteriaceae and metallo-β-lactamase-producing Pseudomonas spp.
Song W; Hong SG; Yong D; Jeong SH; Kim HS; Kim HS; Kim JS; Bae IK
Ann Lab Med; 2015 Mar; 35(2):212-9. PubMed ID: 25729723
[TBL] [Abstract][Full Text] [Related]
11. Investigation of VIM, IMP, NDM-1, KPC AND OXA-48 enzymes in Enterobacteriaceae strains.
Demir Y; Zer Y; Karaoglan I
Pak J Pharm Sci; 2015 May; 28(3 Suppl):1127-33. PubMed ID: 26051720
[TBL] [Abstract][Full Text] [Related]
12. Inactivation or inhibition of AcrAB-TolC increases resistance of carbapenemase-producing Enterobacteriaceae to carbapenems.
Saw HT; Webber MA; Mushtaq S; Woodford N; Piddock LJ
J Antimicrob Chemother; 2016 Jun; 71(6):1510-9. PubMed ID: 26945714
[TBL] [Abstract][Full Text] [Related]
13. [Infectious diseases caused by carbapenemase-producing Enterobacteriaceae--a particular challenge for antibacterial therapy].
Stock I
Med Monatsschr Pharm; 2014 May; 37(5):162-72; quiz 173-4. PubMed ID: 24908928
[TBL] [Abstract][Full Text] [Related]
14. What remains against carbapenem-resistant Enterobacteriaceae? Evaluation of chloramphenicol, ciprofloxacin, colistin, fosfomycin, minocycline, nitrofurantoin, temocillin and tigecycline.
Livermore DM; Warner M; Mushtaq S; Doumith M; Zhang J; Woodford N
Int J Antimicrob Agents; 2011 May; 37(5):415-9. PubMed ID: 21429716
[TBL] [Abstract][Full Text] [Related]
15. Emergence of NDM-1- and IMP-14a-producing Enterobacteriaceae in Thailand.
Rimrang B; Chanawong A; Lulitanond A; Wilailuckana C; Charoensri N; Sribenjalux P; Phumsrikaew W; Wonglakorn L; Kerdsin A; Chetchotisakd P
J Antimicrob Chemother; 2012 Nov; 67(11):2626-30. PubMed ID: 22796889
[TBL] [Abstract][Full Text] [Related]
16. Simple screening tests for detection of carbapenemases in clinical isolates of nonfermentative Gram-negative bacteria.
Noyal MJ; Menezes GA; Harish BN; Sujatha S; Parija SC
Indian J Med Res; 2009 Jun; 129(6):707-12. PubMed ID: 19692754
[TBL] [Abstract][Full Text] [Related]
17. In vitro potentiation of carbapenems with tannic acid against carbapenemase-producing enterobacteriaceae: exploring natural products as potential carbapenemase inhibitors.
Somboro AM; Osei Sekyere J; Amoako DG; Kumalo HM; Khan R; Bester LA; Essack SY
J Appl Microbiol; 2019 Feb; 126(2):452-467. PubMed ID: 30365206
[TBL] [Abstract][Full Text] [Related]
18. Characterization of carbapenemases, extended spectrum β-lactamases and molecular epidemiology of carbapenem-non-susceptible Enterobacter cloacae in a Chinese hospital in Chongqing.
Dai W; Sun S; Yang P; Huang S; Zhang X; Zhang L
Infect Genet Evol; 2013 Mar; 14():1-7. PubMed ID: 23220359
[TBL] [Abstract][Full Text] [Related]
19. Carbapenemases in Enterobacteriaceae: types and molecular epidemiology.
Martínez-Martínez L; González-López JJ
Enferm Infecc Microbiol Clin; 2014 Dec; 32 Suppl 4():4-9. PubMed ID: 25542046
[TBL] [Abstract][Full Text] [Related]
20. Dissemination of IMP-1 metallo- beta -lactamase-producing Acinetobacter species in a Brazilian teaching hospital.
Tognim MC; Gales AC; Penteado AP; Silbert S; Sader HS
Infect Control Hosp Epidemiol; 2006 Jul; 27(7):742-7. PubMed ID: 16807851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
